MOUNTAIN VIEW, Calif., June 17 /PRNewswire/ -- ChemoCentryx, Inc., today announced that it reported positive Phase I results for its novel drug candidate CCX354 at the Annual European Congress of Rheumatology (EULAR).
Stuttgart, Germany Author Publishes New Book
This detailed and thought-provoking book, written in both German and English, examines the problems facing the European Union.
BNA Announces New International Tax Centre to Help Practitioners with Growing Issues
In a time of a growing number of international taxation issues, BNA has launched the BNA International Tax Centre, a comprehensive tax research and transfer pricing library. It offers access to leading practitioners' insights, analysis of complex tax issues, regularly updated news and developments, tax treaties, U.S. international regulations, and more.